Since ancient times, living organisms have produced their own light, a phenomenon known as bioluminescence. Unlike light from the sun or a bulb, this cold light relies on chemical reactions involving molecules like luciferin and luciferase. Researchers such as Raphael Dubois and Edmund Newton Harvey studied these mechanisms in various organisms, from fireflies and bacteria to marine crustaceans.
Research into bioluminescence paved the way for major scientific applications. The identification of fluorescent proteins, such as GFP (Green Fluorescent Protein) discovered by Osamu Shimomura, revolutionized cell biology by enabling non-invasive visualization of biological processes. These advancements earned Shimomura, Martin Chalfie, and Roger Tsien the Nobel Prize in Chemistry in 2008.
More recently, work on optogenetics, initiated by Peter Hegemann, Georg Nagel, and Ernst Bamberg, has enabled the manipulation of neuronal activity using light. By identifying light-sensitive opsins in algae, Karl Deisseroth and Edward Boyden were able to activate specific neurons in mice, opening doors to new understandings of the brain and therapeutic applications.
These advancements have led to remarkable breakthroughs, such as the partial restoration of vision in blind patients through optogenetic therapy. On October 5, 2026, Nagel, Hegemann, and Deisseroth were awarded the Nobel Prize for their fundamental contributions to this field.
